12.06
price up icon3.79%   0.44
after-market 시간 외 거래: 12.09 0.03 +0.25%
loading

Intellia Therapeutics Inc (NTLA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
14.33%
14.24
16.63 9.111 6.957 28.93
Operating Expenses
9.60%
124.24
137.43 153.88 146.00 142.94
Benefits Costs and Expenses
5.13%
124.24
130.96 153.88 146.00 136.37
Costs And Expenses
9.60%
124.24
137.43 153.88 146.00 142.94
Operating Income/Loss
8.95%
-110.00
-120.81 -144.77 -139.04 -114.00
Income/Loss From Continuing Operations Before Tax
3.79%
-110.00
-114.33 -144.77 -146.97 -107.44
Income/Loss From Continuing Operations After Tax
11.44%
-101.25
-114.33 -135.71 -146.97 -107.44
Net Income/Loss
11.44%
-101.25
-114.33 -135.71 -146.97 -107.44
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.22%
103.73
103.50 101.00 96.97 95.50
Diluted Average Shares
0.22%
103.73
103.50 101.00 96.97 95.50
Basic Earnings Per Share
10.91%
-0.98
-1.10 -1.34 -1.52 -1.12
Diluted Earnings Per Share
10.91%
-0.98
-1.10 -1.34 -1.52 -1.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):